- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05649657
Effect of Lifestyle Intervention in Patients With Chronic Kidney Disease on Fitness and Immune Function
August 17, 2025 updated by: Chang Gung Memorial Hospital
To assess the efficacy of a 6-month lifestyle intervention in patients with end-stage renal disease(ESRD), we plan to conduct a self-controlled clinical trial.
34 participants receiving chronic HD will be enrolled.
Each participant will go through three phases: 3-month control, 6-month intervention, and 3-month maintenance.
No intervention will be performed in the control and maintenance phases.
The lifestyle intervention will comprise care from a multidisciplinary team, including a nephrologist, nurse practitioner, physiatrist, and dietitian.
The exercise training component is an in-hospital supervised training 2~3 times weekly for 6 months.
Cyclic aerobic and resistance training will be performed.
Assessment will be performed every three months and 5 times in total, including cardiopulmonary exercise testing, isokinetic quadriceps strength testing, hand grip strength, body composition analysis, Chinese Kidney Disease and Quality of Life questionnaire, self-recorded physical activity, and Mini Nutritional Assessment.
The aim of this study is to assess the efficacy of a lifestyle intervention in patients with chronic kidney disease (CKD) on physical fitness, quality of life, and immunity.
It is hypothesized that the lifestyle intervention will elicit a significant benefit in the aforementioned parameters and will last until the maintenance phase.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The prevalence of end-stage renal disease is high, especially in Taiwan.
Cardiovascular diseases and infection are the major causes of morbidity.
Though evidence is clear that exercise training in this population is beneficial to fitness、quality of life、morbidity, it is seriously underused.
Poor physical fitness is known to associate with high-leveled systemic inflammation and immune dysregulation but the detailed relationship remains unclear in the ESRD population.
Moreover, though exercise improves low physical fitness, available research concerning its effect on the pro-/anti-inflammatory immune response is scarce.
Does supervised lifestyle intervention has the potential to improve physical fitness, and quality of life in patients receiving maintenance hemodialysis (HD)?
To assess the efficacy of a 6-month lifestyle intervention in patients under HD, we plan to conduct a self-controlled clinical trial.
No intervention will be performed in the control and maintenance phases.
The lifestyle intervention will comprise care from a multidisciplinary team, including a nephrologist, nurse practitioner, physiatrist, and dietitian.
The exercise training component is in-hospital supervise training 2~3 times weekly for 6 months.
Cyclic aerobic and resistance training will be performed.
Assessment will be performed every three months and 5 times in total, including cardiopulmonary exercise testing, isokinetic quadriceps strength testing, hand grip strength, body composition analysis, Chinese Kidney Disease and Quality of Life questionnaire, self-recorded physical activity, and Mini Nutritional Assessment.
The aim of this study is to assess the efficacy of a lifestyle intervention in patients under HD on physical fitness, and quality of life.
It is hypothesized that the lifestyle intervention will elicit a significant benefit in the aforementioned parameters and will last until the maintenance phase.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Chang Gung Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- patients who are on HD for longer than 6 months
- under the permission of their nephrologist
- adequately dialyzed (most recent Kt/V > 1.2) and stable during dialysis in the past 3 months
Exclusion Criteria:
- occurrence of hyperkalemia in the past 3 months
- comorbid medical, physical, and mental conditions that contraindicate exercise
- unstable cardiac conditions (eg, unstable angina, heart failure or symptomatic severe aortic stenosis, etc.)
- disabling orthopedic and neuromuscular diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: hemodialysis patients with exercise training intervention
The participants under hemodialysis for over 3 months will go through three phases: 3-month control, 6-month intervention, and 3-month maintenance.
No intervention will be performed in the control and maintenance phases
|
Two options for the participants to choose from.
First, a home-based program.
The participant will be requested to wear a heart rate recorder during home exercise.
Second, a hospital-based program.
The participants visit the rehabilitation center twice weekly to receive supervised exercise therapy.
The exercise prescription comprises aerobic and resistance training.
The intensity is set initially at ventilatory anaerobic threshold and gradually titrated up to respiratory compensatory point based on the breath-by-breath cardiopulmonary exercise testing.
The duration is 25~35 minutes per session plus a 5-minute warm-up and 5-min cool-down.
The frequency is 2~3 sessions per week and about 70 sessions in total.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Peak Oxygen Consumption
Time Frame: 1 year
|
cardiopulmonary exercise testing
|
1 year
|
|
Inflammatory Cytokines
Time Frame: 1 year
|
Interleukin (IL)-6 concentration was detected in plasma using the BD Cytometric Bead Array (CBA) Human Inflammatory Cytokines Kit (Becton-Dickinson) and analyzed with FCAP Array™ software .
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To evaluate the association between fitness and immune responses by the questionnaire of Hong Kong Chinese Kidney Disease and Quality of Life
Time Frame: three years
|
The minimum and maximum values of the Hong Kong Chinese Kidney Disease and Quality of Life questionnaire are 0 and 100, separately.
The higher scores mean a better outcome.
|
three years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Shu-Chun Huang, MD, PhD, Chang Gung Memorial Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Actual)
February 28, 2025
Study Completion (Actual)
February 28, 2025
Study Registration Dates
First Submitted
November 7, 2022
First Submitted That Met QC Criteria
December 12, 2022
First Posted (Actual)
December 14, 2022
Study Record Updates
Last Update Posted (Actual)
August 19, 2025
Last Update Submitted That Met QC Criteria
August 17, 2025
Last Verified
October 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202201244B0A3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on End-stage Renal Disease (ESRD)
-
Rockwell Medical Technologies, Inc.CompletedEnd-Stage Renal Disease (ESRD)United States, Canada
-
National Taiwan University HospitalUnknown
-
University of Kansas Medical CenterCompletedEnd-stage Renal Disease (ESRD) | Chronic Kidney Disease (CKD)United States
-
Outset MedicalCompletedAcute Kidney Injury | End Stage Renal Disease (ESRD) | End Stage Renal Disease on DialysisUnited States
-
FibroGenAstraZenecaCompletedAnemia Associated With End Stage Renal Disease (ESRD)United States
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Canada
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Spain
-
Ottawa Hospital Research InstituteHeart and Stroke Foundation of OntarioCompletedEnd-stage Renal Disease (ESRD) | Kidney DiseaseCanada
-
Bristol-Myers SquibbCompletedThrombosis | Renal Impairment | Factor XI | ESRD (End-Stage Renal Disease)United States
-
Icahn School of Medicine at Mount SinaiCompletedEnd Stage Renal Disease (ESRD)United States
Clinical Trials on Cyclic aerobic and resistance training
-
University of BarcelonaCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Duke UniversityCompleted
-
Onassis Cardiac Surgery CentreInstitute of Cardiology, Warsaw, Poland; Asklepieion Voulas General HospitalCompletedHeart FailureGreece, Poland
-
Biomedical Research Institute of New MexicoBaylor College of Medicine; National Institute on Aging (NIA)Completed
-
Riphah International UniversityNot yet recruiting
-
University of Illinois at ChicagoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Vascular Diseases | HypertensionUnited States
-
Riphah International UniversityCompletedCardiovascular DiseasesPakistan
-
National Cardiovascular Center Harapan Kita Hospital...Completed
-
Nanjing University of Traditional Chinese MedicineGuangxi Medical University; Southeast University, ChinaUnknown
-
University of AarhusOxford Brookes UniversityCompleted